Tourette Syndrome
📧 Sign up to get email alerts when something new happens for Tourette Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: A Study to Explore the Effect of Sepranolone in Tourette Syndrome [Phase 2]
Phase 2 trial update for Sepranolone in Tourette Syndrome has been completed.
-
CLINICAL_TRIALS trial_result · 2023-04-27Clinical Trial Update: Evaluating the Efficacy and Safety of Yi-Gan San in Children and Adolescents With Tourette's Disorder [Phase 2]
Phase 2 trial update evaluating the efficacy and safety of Yi-Gan San in children and adolescents with Tourette's Disorder and tic disorders…
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Outcomes Mandate National Integration With Cannabis as Medicine [Phase 2]
Phase 2 clinical trial update focusing on integrating cannabis as medicine for various chronic pain conditions, with status currently UNKNOW…
-
CLINICAL_TRIALS trial_result · 2022-05-24Clinical Trial Update: Proof of Concept Study of an Oral Orthotic to Reduce Tic Severity in Chronic Tic Disorder and Tourette Syndrome [NA]
A completed proof-of-concept study evaluating an oral orthotic to reduce tic severity in Tourette Syndrome and Chronic Tic Disorder; results…
-
CLINICAL_TRIALS trial_result · 2022-05-17Clinical Trial Update: Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome [Phase 2]
Phase 2 trial on NBI-98854 in pediatric Tourette syndrome was terminated; results posted in 2022.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-05-12Clinical Trial Update: Thalamic Deep Brain Stimulation for Tourette Syndrome [Phase 2]
Phase 2 clinical trial update on thalamic deep brain stimulation for Tourette Syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-19Clinical Trial Update: Rollover Study for Continuing NBI-98854 Administration in Pediatric Subjects With Tourette Syndrome [Phase 2]
A phase 2 rollover study evaluating continuing administration of NBI-98854 in pediatric Tourette Syndrome was terminated with results posted…
-
CLINICAL_TRIALS trial_result · 2022-02-23Clinical Trial Update: Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome [Phase 2]
Phase 2 open-label safety and tolerability study of NBI-98854 in pediatric Tourette syndrome completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-07Clinical Trial Update: Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder [Phase 3]
Phase 3 trial update on safety and tolerability of once-weekly oral aripiprazole in children and adolescents with Tourette's Disorder; resul…
-
CLINICAL_TRIALS trial_result · 2021-06-28Clinical Trial Update: Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome [Phase 2]
Phase 2 clinical trial assessing safety, tolerability, and efficacy of NBI-98854 for pediatric Tourette syndrome has been completed with res…
-
CLINICAL_TRIALS trial_result · 2021-04-29Clinical Trial Update: Safety and Tolerability Study of NBI-98854 for the Treatment of Subjects With Tourette Syndrome [Phase 2]
Phase 2 safety and tolerability study of NBI-98854 for Tourette Syndrome has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-23Clinical Trial Update: Evaluation of Safety and Tolerability of Long-term TEV-50717 (Deutetrabenazine) for Treatment of Tourette Syndrome in Children and Adolescents [Phase 3]
Phase 3 trial evaluating long-term safety and tolerability of deutetrabenazine (TEV-50717) for Tourette syndrome in children and adolescents…
-
CLINICAL_TRIALS trial_result · 2021-01-15Clinical Trial Update: Safety and Efficacy Study of NBI-98854 in Children and Adolescents With Tourette Syndrome [Phase 2]
Phase 2 trial of NBI-98854 in children and adolescents with Tourette syndrome completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-29Clinical Trial Update: Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's Syndrome [Phase 3]
Phase 3 trial evaluating aripiprazole oral solution for Tourette syndrome in children and adolescents has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-10Clinical Trial Update: CANNAbinoids in the Treatment of TICS (CANNA-TICS) [Phase 3]
Phase 3 trial update for cannabinoids in Tourette syndrome and tic disorders has completed.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS) [Phase 3]
Phase 3 trial of TEV-50717 for Tourette syndrome completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents [Phase 2, Phase 3]
Phase 2/3 trial assessing deutetrabenazine (TEV-50717) for reducing tics in children and adolescents with Tourette Syndrome has completed wi…
-
CLINICAL_TRIALS trial_result · 2020-05-07Clinical Trial Update: Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome [Phase 2]
Phase 2 clinical trial update on NBI-98854 assessing safety and efficacy in adults with Tourette Syndrome; results completed with posted res…
-
CLINICAL_TRIALS trial_result · 2020-04-13Clinical Trial Update: Transcranial Magnetic Stimulation for Children With Tourette's Syndrome [NA]
A completed clinical trial on transcranial magnetic stimulation for Tourette syndrome in children; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder [Phase 2]
Phase 2 trial update for ABX-1431 in adults with Tourette Syndrome or Chronic Motor Tic Disorder has completed enrollment and status.
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: Efficacy of a Therapeutic Combination of Dronabinol and PEA for Tourette Syndrome [Phase 2]
Phase 2 trial assessing the efficacy of a combination of dronabinol and palmitoylethanolamide (PEA) for Tourette Syndrome has completed with…
-
CLINICAL_TRIALS trial_result · 2019-05-23Clinical Trial Update: Thalamic Deep Brain Stimulation for Tourette Syndrome [Phase 2, Phase 3]
Clinical trial update for thalamic deep brain stimulation in Tourette syndrome showing completed phases 2 and 3.
-
CLINICAL_TRIALS trial_result · 2019-04-25Clinical Trial Update: Augmentation of Brief Habit Reversal Training With D-cycloserine or Placebo [NA]
A completed clinical trial evaluating augmentation of Brief Habit Reversal Training with D-cycloserine or placebo for Tourette Disorder and …
-
CLINICAL_TRIALS trial_result · 2019-04-01Clinical Trial Update: ABF Tourette's Disorder Post Marketing Surveillance Study
Post-marketing surveillance study on ABF for Tourette's Disorder has completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2018-08-29Clinical Trial Update: A Study to Examine the Efficacy of a Therapeutic THX-110 for Tourette Syndrome [Phase 2]
Phase 2 clinical trial evaluating THX-110 for Tourette Syndrome is reported as ongoing with unknown status.